Structure and oligomerization state of the C-terminal region of the Middle East respiratory syndrome coronavirus nu

  • 1 0 0
  • Like this paper and download? You can publish your own PDF file online for free in a few minutes! Sign Up

Structure and oligomerization state of the C-terminal region of the Middle East respiratory syndrome coronavirus nu

research papers ISSN 2059-7983 Structure and oligomerization state of the C-terminal region of the Middle East respira

363 99 2MB

Pages 8 Page size 609.675 x 793.701 pts Year 2019

Report DMCA / Copyright

DOWNLOAD FILE

Recommend Papers

File loading please wait...
Citation preview

research papers

ISSN 2059-7983

Structure and oligomerization state of the C-terminal region of the Middle East respiratory syndrome coronavirus nucleoprotein Thi Hong Van Nguyen,a,b Julie Lichie`re,a,b Bruno Canard,a,b Nicolas Papageorgiou,a,b Sarah Attoumani,a,b Franc¸ois Ferrona,b*‡ and Bruno Coutarda,b*‡

Received 11 July 2018 Accepted 22 October 2018

Edited by R. McKenna, University of Florida, USA ‡ These authors contributed equally. Keywords: nucleoproteins; Middle East respiratory syndrome coronavirus; MERS-CoV; Coronaviridae; X-ray diffraction; SAXS. PDB reference: C-terminal domain of MERS-CoV nucleocapsid, 6g13 Supporting information: this article has supporting information at journals.iucr.org/d

a

Aix-Marseille Universite´, AFMB UMR 7257, 13288 Marseilles, France, and bCNRS, AFMB UMR 7257, 13288 Marseilles, France. *Correspondence e-mail: [email protected], [email protected]

Middle East respiratory syndrome coronavirus (MERS-CoV) is a human pathogen responsible for a severe respiratory illness that emerged in 2012. Structural information about the proteins that constitute the viral particle is scarce. In order to contribute to a better understanding of the nucleoprotein (N) in charge of RNA genome encapsidation, the structure of the C-terminal domain of N from MERS-CoV obtained using single-crystal X-ray diffraction is ˚ resolution. The molecule is present as a dimer in the reported here at 1.97 A crystal structure and this oligomerization state is confirmed in solution, as measured by additional methods including small-angle X-ray scattering measurements. Comparisons with the structures of the C-terminal domains of N from other coronaviruses reveals a high degree of structural conservation despite low sequence conservation, and differences in electrostatic potential at the surface of the protein.

1. Introduction

# 2019 International Union of Crystallography

8

Middle East respiratory syndrome coronavirus (MERS-CoV) is the etiological agent responsible for outbreaks of a severe respiratory disease in the Middle East, with sporadic occurrence in Europe, Africa, Asia and America. MERS-CoV belongs to lineage C of the Betacoronavirus genus within the Coronaviridae family, one of the four viral families (together with Arteriviridae, Mesoniviridae and Roniviridae) that form the Nidovirales order. This group of viruses includes the largest-sized RNA genomes known, i.e. Roniviridae (26 kb) and Coronaviridae (from 26.3 to 31.7 kb), as well as the medium-sized Mesoniviridae (20.2 kb) and the small-sized Arteriviridae (12.7–15.7 kb) (Adams et al., 2013). Despite having a positive-sense single-stranded RNA genome, all of these viruses protect their genomes of dissimilar size with a nucleoprotein (N). The 50 part of the MERS-CoV genome codes for the polyproteins pp1a and pp1ab, which are processed into 16 nonstructural proteins involved in the replication complex. The 30 part of the genome codes for viral structural proteins and several accessory proteins, which are translated from a set of subgenomic mRNAs. Among these proteins, the nucleoprotein (N) is a multifunctional protein that plays roles in genome encapsidation (reviewed in Chang et al., 2014), RNA synthesis during replication, host translational shutoff and innate immunity disruption (McBride et

https://doi.org/10.1107/S2059798318014948

Acta Cryst. (2019). D75, 8–15

research papers al., 2014). The coronavirus N is a 40 kDa protein organized into two folded domains that are called the N-terminal domain (NTD) and the C-terminal domain (CTD). They are separated by a disordered region (called LKR) containing a serine/ arginine stretch which could regulate the functions of N upon phosphorylation (He et al., 2004; Surjit et al., 2005; Peng et al., 2008; Wu et al., 2009). Despite many studies, the mechanism by which the RNA genome is encapsidated by N has not been fully unraveled. Indeed, the structure of full-length N is not known, probably owing to its flexibility, and the structures of the NTD and the CTD have been explored separately. However, structural and functional data led to a consensus model in which the formation of the ribonucleocapsid (RNP) requires both multi-site interactions of the RNA along N and oligomerization of N (McBride et al., 2014). In this model, dimers of N generated through a CTD–CTD dimerization process represent the basic module of the RNP (Yu et al., 2006; Jayaram et al., 2006). A recent low-resolution electronmicroscopy analysis of N from Murine hepatitis virus seems to converge towards a proposal in which N assembles as small oligomers (from dimers to tetramers) and forms a helical structure in complex with the RNA genome (Gui et al., 2017). The structure of the MERS-CoV NTD has been determined using X-ray crystallography (Papageorgiou et al., 2016). The overall structure is conserved and consists of a five-stranded antiparallel -sheet core domain with disordered loops of varying length connecting the strands. Sequence analysis of the C-terminal region of MERS-CoV N suggests that the CTD is 122 amino acids in length (amino acids 239–361 of the MERS-CoV N sequence) followed by an intrinsically disordered region of 50 amino acids. The structures of CTDs from Human coronavirus NL63 (HCoV-NL63), Avian infectious bronchitis virus (IBV), Severe acute respiratory syndrome coronavirus (SARS-CoV) and Murine hepatitis virus (MHV) have been determined. The structures revealed a conserved structural organization in which the CTD forms a dimer with an intermolecular antiparallel fourstranded -sheet (Yu et al., 2006; Jayaram et al., 2006; Chen et al., 2007; Ma et al., 2010; Szelazek et al., 2017). This -sheet is surrounded by eight -helices and 310-helices. The CTD displays a positively charged area, highlighting that the CTD is a possible RNA-binding module. However, the surface of the charged area can vary from one viral isoform to another, suggesting variability in its RNA-binding affinity (Chen et al., 2007). Several studies support the idea that RNA binding can occur along the N protein, with multiple binding sites acting cooperatively to form a ribonucleocapsid, as reviewed by Chang et al. (2014). However, no structure of full-length coronavirus N is available to support this hypothesis, most likely because the recombinant protein is not stable in solution. In this study, we present the crystallographic structure of ˚ . In addition, we the MERS-CoV CTD at a resolution of 1.97 A report size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALLS) and small-angle X-ray scattering (SAXS) studies of the CTD in order to gain insight into its structural organization in solution. Acta Cryst. (2019). D75, 8–15

2. Materials and methods 2.1. Protein production, purification and characterization

The codon-optimized DNA encoding the CTD (amino acids 239–362) of the MERS-CoV nucleoprotein (strain Betacoronavirus England 1, accession No. KC164505) was synthesized by GenScript. The coding sequence of the CTD was amplified by a two-step PCR before cloning into the expression vector pMCOX20A to enable the fusion of a cleavable thioredoxin/ 6His tag at the N-terminus (Lantez et al., 2011). The protein was then produced in Escherichia coli T7 Express (DE3) cells (New England Biolabs). Expression was induced overnight at 290 K in Terrific Broth medium with 0.5 mM IPTG when the OD600 nm of the culture reached 0.6. The purification of the protein and tag removal was performed under nondenaturing conditions, as described previously (Lantez et al., 2011). The final preparative size-exclusion chromatography (SEC) step was performed in 10 mM HEPES, 300 mM NaCl pH 7.5. In order to confirm the oligomerization state of the CTD, analytical SEC with online multi-angle laser light scattering, absorbance and refractive-index (MALLS/UV/RI) detectors was carried out on an Alliance 2695 HPLC system (Waters) using a Silica Gel KW802.5 column (Shodex) equilibrated in 10 mM HEPES, 150 mM NaCl pH 7.5. Measurement was performed using a triple-angle light-scattering detector (miniDAWN TREOS, Wyatt Technology), a quasi-elastic light-scattering instrument (DynaPro, Wyatt Technology) and a differential refractometer (Optilab rEX, Wyatt Technology). Determination of the molecular weight from the MALLS data was performed using the ASTRA V software (Wyatt Technology). 2.2. Protein crystallization

Crystallization trials were performed by the sitting-drop vapor-diffusion method at 293 K in a 96-well Swissci plate using a nanodrop-dispensing robot (Mosquito, TTP Labtech) by screening three different ratios of protein (300, 200 and 100 nl) versus a constant volume of precipitant (100 nl). Wide intensive screening conditions were explored and crystals were found in condition No. 10 (0.2 M ammonium nitrate, 2.2 M ammonium sulfate) from The AmSO4 Suite (Qiagen). Optimal crystallization conditions were obtained by mixing 200 nl protein solution at 11.5 mg ml1 with 100 nl reservoir solution. Crystals appeared within 48 h and were harvested after a week. The crystals of the MERS-CoV CTD were cryoprotected using 100% trimethylamine N-oxide (TMAO) prior to flash-cooling in liquid nitrogen at 110 K. 2.3. Data collection and processing

Diffraction data were collected on the ID23 beamline at the European Synchrotron Radiation Facility (ESRF), Grenoble, France using the large in-vacuum PILATUS 6M-F detector ˚ with 0.1 (Dectris, Switzerland) at a wavelength of 0.9787 A oscillation, 0.037 s exposure time and a temperature of 100 K. A total of 1400 images were measured and were subsequently processed using the autoPROC toolbox (Vonrhein et al., Nguyen et al.



C-terminal region of the MERS-CoV nucleoprotein

9

research papers 2011). The data were integrated using XDS (Kabsch, 2010), and were then analysed with POINTLESS (Evans, 2006) and scaled with AIMLESS (Evans & Murshudov, 2013). The ˚ resolution to MERS-CoV CTD data were truncated at 1.97 A satisfy completeness and I/(I) > 2 statistics. Phasing was performed by molecular replacement using Phaser (McCoy et al., 2007). A search model was generated using CHAINSAW (Stein, 2008) after first using Expresso (Di Tommaso et al., 2011) to identify the structure with the closest sequence homology (46% identity) as that of the SARS CoV CTD, which was obtained by NMR (PDB entry 2jw8; Takeda et al., 2008) and by X-ray diffraction (PDB entry 2cjr; Chen et al., 2007). Refinement was performed by successive and alternate rounds of refinement with BUSTER (Bricogne et al., 2017) and model improvement using Coot (Emsley et al., 2010). The final model was evaluated using MolProbity (Williams et al., 2018). Surface electrostatics were calculated using APBS (Baker et al., 2001). Figures showing structures and alignments were prepared with UCSF Chimera (Pettersen et al., 2004) and with SeaView (Gouy et al., 2010) and ESPript/ENDscript (Robert & Gouet, 2014), respectively. The X-ray structure was validated and deposited in the Protein Data Bank with accession code 6g13. Data-collection and refinement statistics are shown in Table 1. 2.4. Small-angle X-ray scattering (SAXS)

SAXS measurements were recorded on beamline BM29 at the ESRF using a PILATUS 1M detector at a sample-todetector distance of 2.43 m and a wavelength of 0.09919 nm (12.51 keV). SAXS intensity was measured in the range 0.025–5 nm1. The scattering vector s is defined here as s = (4/)sin, where  is the wavelength of the incident radiation in nanometres and  is half of the angle between the incident and scattered radiation. Measurements were obtained at seven protein concentrations in the range 0.14–8.51 mg ml1. The protein buffer consisted of 10 mM HEPES, 300 mM NaCl pH 7.5. All samples were centrifuged for 15 min at 15 000g prior to the experiment to minimize the contribution from aggregated particles. Measurements were made for each protein

Table 1 Data processing, structure solution and refinement. Values in parentheses are for the highest resolution shell. Data processing ˚) Wavelength (A Space group ˚) a, b, c (A , , ( ) ˚) Resolution range (A Total No. of reflections No. of unique reflections Completeness (%) Multiplicity hI/(I)i Rmeas CC1/2 ˚ 2) Wilson B factor (A Structure solution and refinement No. of reflections, working set No. of reflections, test set (5.27%) Rcryst Rfree No. of non-H atoms Total Protein Ligand Water R.m.s. deviations ˚) Bonds (A Angles ( ) ˚ 2) Average B factors (A Overall Protein Ligand Water Ramachandran plot Favored (%) Allowed (%) Outliers (%) Clashscore

0.9787 P3121 120.7, 120.7, 92.6 90.0, 90.0, 120.0 69.33–1.97 (2.04–1.97) 110454 (10949) 55298 (5473) 100 (99.96) 2.0 (2.0) 15.91 (2.47) 0.03473 (0.4165) 0.998 (0.91) 43.9 55294 (5475) 2912 (303) 0.19 0.22 3970 3632 28 310 0.013 1.64 64.97 64.76 74.70 66.57 98.17 1.83 0 4.43

concentration at 4 C by injecting 45 ml protein sample into a 1.8 mm capillary with flow to minimize radiation damage. Each measurement consisted of ten exposures of 1 s, which were subsequently averaged into a unique intensity profile for each measurement. Buffer reference SAXS measurements were performed before and after the measurement for each protein sample. The forward scattering intensity was calibrated using BSA as a reference at 5 mg ml1. Data were processed with the ATSAS package (Petoukhov & Svergun, 2007). The ten frames of 1 s exposure were averaged using PRIMUS (Konarev et al., 2003). Frames affected by radiation damage were excluded, while the buffer background was subtracted from the sample-scattered intensity signal.

3. Results and discussion 3.1. MERS-CoV CTD behaves as a dimer in solution

Figure 1 MALLS/UV/refractometry/SEC analysis. The right y axis represents the OD at 280 nm and the left y axis represents the molar mass in kDa. The absorption peaks are shown as a continuous black line; the blue dots indicate the molar mass.

10

Nguyen et al.



C-terminal region of the MERS-CoV nucleoprotein

Characterization of the purified CTD protein using analytical SEC with online multi-angle laser light scattering (SECMALLS) shows that the protein is mainly organized in particles of 29 kDa (elution peak at 20.5 min) corresponding to the molecular weight of a CTD dimer. A second minor population (elution peak at 22.5 min) that was only observed in the analytical SEC and that also displays an apparent Acta Cryst. (2019). D75, 8–15

research papers molecular weight (MW) of 29 kDa probably corresponds to the CTD interacting with the silica matrix. Thus, recombinant MERS-CoV CTD is organized in dimers in solution (Fig. 1); this result is consistent with previous observations and with the proposal that N dimerizes through its CTD, forming the core unit leading to assembly of the N polymer (Yu et al., 2006; Jayaram et al., 2006). To further characterize the oligomerization state of the protein in solution, we studied the protein using SAXS. Fig. 2(a) shows the Guinier region sRg = 0.1–1.29 considering a globular type of protein, showing that no trend towards aggregation is present with increasing concentration. Data are shown as open circles and linear regression of data is shown as red lines. For all concentrations we found the same value of

radius of gyration Rg, with a mean value (taken over all seven concentrations) of Rg = 2.0  0.3 nm. Mass estimation using the SAXS profile of a standard BSA molecule returns a molecular weight (MW) of 29.32 kDa, which is in agreement with the previous SEC/MALLS measurements. This value is compatible with the MW of a dimer, knowing that the calculated MW of the monomer based on the protein sequence is 14.22 kDa. Again, this result is consistent with previous observations (Yu et al., 2006; Jayaram et al., 2006) and shows that this dimer is not transient but rather stable as it is not significantly affected by low or high protein concentrations. In order to interpret our data and propose a molecular model, we used a merged data profile truncated between the

Figure 2 SAXS analysis of the MERS-CoV CTD. (a) Guinier plot for all concentrations showing the absence of aggregation. (b) GNOM fit of the merged profile. (c) Distance distribution P(r) of the merged data. (d) CRYSOL fit of the model (PDB entry 6g13) with the experimental data (blue line) and CRYSOL fit of an enhanced model featuring the disordered N-terminal region residues modeled by EOM (red line). The three corresponding enhanced models calculated by EOM are shown also in the inset in (d). Acta Cryst. (2019). D75, 8–15

Nguyen et al.



C-terminal region of the MERS-CoV nucleoprotein

11

research papers recommended typical values of the wavevector smin = /Dmax (0.5 nm1) and smax = 7/Rg (3.5 nm1) (Svergun, 1992). In Fig. 2(b) we show the output of the GNOM numerical fit over the merged profile, while Fig. 2(c) shows the corresponding distance distribution P(r). The latter smoothly converges to zero for a maximum particle dimension of Dmax = 6.49 nm. The measured dimer dimension of the crystallographic structure that we determined (PDB entry 6g13) is smaller at 5.6 nm. However, ten residues in the N-terminal region of the monomer were not resolved in the crystallographic structure (Thr237–Lys247). These residues contribute to the extra overall length of the molecule. To verify this hypothesis, we modeled these regions using EOM analysis (Ensemble Optimization Method; Bernardo´ et al., 2007). Using Coot, the ten missing residues were added to the globular part of the molecule and were modeled by EOM keeping the globular part fixed. The EOM calculations resulted in three possible molecular conformations. CRYSOL fits the measured scattering curve with a simulated scattering curve generated using a known X-ray crystal structure. In Fig. 2(d) we show two CRYSOL fits using the two PDB model structures with and without additional amino acids at the N-terminus. More precisely, the CRYSOL fit shown as a blue continuous line corresponds to the crystallographic dimer structure (PDB entry 6g13) with no addition of any supplementary amino acids. The red continuous line is the CRYSOL fit corresponding to a mixture of the three molecular conformations calculated by EOM after the addition of the missing amino acids to the N-terminal region of each monomer. At the bottom of the figure, the difference between the data and the CRYSOL fit is shown. The blue difference spectrum corresponds to the CRYSOL fit of PDB entry 6g13, while the red difference spectrum corresponds to the CRYSOL fit of the

structure calculated by EOM. We observe that in the higher resolution range (between 2 and 3.5 nm1), consideration of the enhanced model calculated by EOM improves the fit. This result suggests that the core domain is a dimer in solution, for which a certain flexibility is expected at the N-terminus. 3.2. Structure of the MERS-CoV CTD

A dimer of the MERS-CoV CTD was crystallized. Crystals of an apparent cubic shape with a side length of 150 mm were obtained after 3–5 days. The MERS-CoV CTD crystallized in space group P3121. The asymmetric unit was constituted of two identical dimers rotated by 90 around two axes, with the second dimer being in the center of the first (Fig. 3a). The ˚ resolution. The dimer is structure was refined to 1.97 A formed by two molecules related by a noncrystallographic twofold axis and overall looks like a rectangular slab (Fig. 3b). An -helix bundle is on one side of the slab, while the other side is formed by the flat surface of a four-stranded -sheet flanked by two flexible loops. Each monomeric subunit has an ( + ) fold constituted of five short -helices and four turns () forming a semi-ring, from which two antiparallel -strands protrude (Fig. 3c). It is interesting to note that several residues which are not in contact with adjacent protomers present a high degree of flexibility, presumably leading to poor electron density. Indeed, in the final refined structure we were unable to build several residues of the N-terminus (Thr237–Lys248) or of the loop between the two strands (Asp320–Gly322). This is consistent with the SAXS analysis (see Section 3.1) and shows that the crystallographic structure corresponds to a biological assembly behaving as in solution. The analysis of the hydrophobic surface of a monomer (Fig. 4) shows the presence of three hydrophobic patches that

Figure 3 The MERS-CoV CTD structure in different orientations. (a) Asymmetric unit illustrating the two dimers at 90 rotation about two axes (dimer 1 is shown in green and red, and dimer 2 is shown in yellow green and blue). (b) Clipped monomers shown in ribbon representations and in different orientations, showing how the two chains (green and cream) are intertwined. (c) Ribbon representation of the MERS-CoV CTD structure. Helices are colored magenta, strands are colored green and random coils are colored cream; secondary structures are labeled.

12

Nguyen et al.



C-terminal region of the MERS-CoV nucleoprotein

Acta Cryst. (2019). D75, 8–15

research papers interact with the secondary-structure elements of the other protomer. The first patch on the top interacts with helix 5 (Fig. 4), the second patch stacks the core of the two -strands (Fig. 4) and finally the last patch opposite to the second patch interacts with the N-terminal pseudo-turn 1 (Fig. 4). We can infer from this analysis that the driving force of the dimerization is hydrophobic, giving the overall idea of a ‘clipping’ mechanism. The core secondary structures of each protomer are tightly intertwined, making this dimer a cornerstone element in the assembly of the ribonucleoprotein, the overall structure of which still needs to be defined. Based on the recent EM analysis (Gui et al., 2017) and prior crystallographic studies on homologous domains (Yu et al., 2006; Jayaram et al., 2006; Ma et al., 2010), this CTD dimer would be the building block of the assembly of a polymeric ribonucleoprotein. Indeed, this assembly is compatible with a head-to-head subunit leading to a helical filament. In this proposed model the growth of the filament is sideways (Ma et al., 2010). The unique asymmetric unit arrangement observed in the MERS-CoV CTD (Fig. 3a), in which the middle of the -helix bundle of one dimer can interact with the side of the second dimer, suggests that a dimer could prevent the addition of an another ‘sideways dimer’. In such a scenario one dimer could act as a ‘cap’ to prevent further polymerization or regulate the growth of the filament (Supplementary Fig. S1). This type of

regulation is reminiscent of the growth control of actin filaments by steric hindrance at one end (Shekhar et al., 2016). 3.3. MERS-CoV CTD sequence and structure conservation

Sequence comparison against the PDB shows that the MERS-CoV CTD has 23–46% identity to homologous domains, including those from IBV, HCoV-NL63 and SARSCoV. The overall alignment (Supplementary Fig. S2a) shows 8.9% identity, highlighting the key residues that are conserved. Considering their positions in the structure, either buried or in loops, we infer that these residues play a structural role to mainly ensure proper folding and/or dimerization (Supplementary Fig. S2b). Superposition of the corresponding structures (Supplementary Fig. S3) with the MERS-CoV CTD shows that the folds are virtually identical, with the exception of the flexible ends and the insertion into the loop. 3.4. MERS-CoV CTD surface electrostatic conservation

In spite of low overall sequence conservation, the properties of the residues are fairly conserved, with an overall similarity of 60%. Analysis of the electrostatic surface highlights these similar characteristics between the MERSCoV, SARS-CoV and IBV CTDs, and almost an inversion of the charges in the HCoV-NL63 CTD. Indeed, in the first three

Figure 4 Hydrophobicity analysis of MERS-CoV CTD. (a) Surface hydrophobicity showing the hydrophobic potential of a monomer represented by a gradient colored from magenta (high) to cyan (low). (b) Surface representation of the MERS-CoV CTD surface hydrophobicity with the second chain of the dimer. Acta Cryst. (2019). D75, 8–15

Nguyen et al.



C-terminal region of the MERS-CoV nucleoprotein

13

research papers

Figure 5 MERS-CoV CTD surface electrostatic comparison with homologous viral domains. The structures presented are from IBV (PDB entry 2ca1; Jayaram et al., 2006), HCoV-NL63 (PDB entry 5epw; Szelazek et al., 2017), SARS-CoV (PDB entry 2cjr; Chen et al., 2007) and MERS-CoV (PDB entry 6g13). The surface electrostatic potential calculated by APBS is shown from 7kT/e (red) to +7kT/e (blue).

dimers the flat side is mostly neutral, while in HCoV-NL63 the charge is negative (Fig. 5, bottom row). On the -bundle side, a strong positively charged patch is also observed bordering the top and bottom of the dimer, while for the HCoV-63 CTD the bottom and -bundle sides are either mostly neutral, with a small positive patch in the center of the dimer (Fig. 5, top row). These differences are surprising considering that the sequence of the HCoV-NL63 CTD is not the most distant from that of the MERS-CoV CTD (Supplementary Fig. S2c). However, functional studies underscore the role of the CTD in the recognition of the packaging signal in coronaviruses such as Mouse hepatitis virus (Kuo et al., 2014). In particular, MERS-CoV CTD is able to bind a 45-nucleotide stem-loop structure of the packaging signal sequence (Hsin et al., 2018). This observation is consistent with previous observations on SARS-CoV N, where the C-terminal domain alone is able to bind RNA but would rather act in cooperation with other RNA-binding sites along N for formation of the ribonucleocapsid (Chang et al., 2009). In contrast, the CTD of HCoVNL63, which lacks the positively charged area observed in MERS and SARS-CoV CTD, is not, or is at least poorly, able to bind RNA (Zuwała et al., 2015). Therefore, the structural information described in this study may help to reveal the residues involved in the specific recognition of the packaging signal or possible differences in the mechanisms of RNP assembly. Aside from its structural role in RNA packaging, MERSCoV N could also be involved in disease severity by upregulating the cytokine CXCL 10 (Aboagye et al., 2018). The C-terminal part of N (amino acids 196–413) is sufficient to overexpress CXCL10 and the differences between the charge organization on the CTD in viruses leading to severe

14

Nguyen et al.



C-terminal region of the MERS-CoV nucleoprotein

syndromes (SARS-CoV and MERS-CoV) and those leading to mild symptoms (HCoV-NL63) could also be investigated in light of the infection outcomes. Overall, the structural determination of the MERS-CoV CTD reported here allows it to be proposed that the MERSCoV CTD plays a key role in the formation of the RNP in a similar fashion to other CTDs, and that the CTD might also recruit specific RNA sequences by a mechanism that remains to be elucidated.

Acknowledgements The authors would like to thank the reviewers for their time and useful comments to improve the manuscript. The authors also thank the ESRF for the provision of synchrotron beam time at BM29 and the ID23-1 staff for support during data collection.

Funding information This work was supported by the SILVER Large Scale Collaborative Project (grant agreement No. 260644) of the European Union Seventh Framework, the French Infrastructure for Integrated Structural Biology (FRISBI; ANR10-INSB-05-01) and the Fondation Infection Mediterranne´e.

References Aboagye, J. O., Yew, C. W., Ng, O.-W., Monteil, V. M., Mirazimi, A. & Tan, Y.-J. (2018). Biosci. Rep. 38, BSR20181059. Adams, M. J., King, A. M. & Carstens, E. B. (2013). Arch. Virol. 158, 2023–2030. Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. (2001). Proc. Natl Acad. Sci. USA, 98, 10037–10041. Acta Cryst. (2019). D75, 8–15

research papers Bernado´, P., Mylonas, E., Petoukhov, M. V., Blackledge, M. & Svergun, D. I. (2007). J. Am. Chem. Soc. 129, 5656–5664. Bricogne, G., Blanc, E., Brandl, M., Flensburg, C., Keller, P., Paciorek, W., Roversi, P., Sharff, A., Smart, O. S., Vonrhein, C. & Womack, T. O. (2017). BUSTER. Global Phasing Ltd., Cambridge, England. Chang, C.-K., Hou, M.-H., Chang, C.-F., Hsiao, C.-D. & Huang, T.-H. (2014). Antiviral Res. 103, 39–50. Chang, C.-K., Hsu, Y.-L., Chang, Y.-H., Chao, F.-A., Wu, M.-C., Huang, Y.-S., Hu, C.-K. & Huang, T.-H. (2009). J. Virol. 83, 2255– 2264. Chen, C.-Y., Chang, C.-K., Chang, Y.-W., Sue, S.-C., Bai, H.-I., Riang, L., Hsiao, C.-D. & Huang, T.-H. (2007). J. Mol. Biol. 368, 1075– 1086. Di Tommaso, P., Moretti, S., Xenarios, I., Orobitg, M., Montanyola, A., Chang, J.-M., Taly, J.-F. & Notredame, C. (2011). Nucleic Acids Res. 39, W13–W17. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. Evans, P. (2006). Acta Cryst. D62, 72–82. Evans, P. R. & Murshudov, G. N. (2013). Acta Cryst. D69, 1204–1214. Gouy, M., Guindon, S. & Gascuel, O. (2010). Mol. Biol. Evol. 27, 221– 224. Gui, M., Liu, X., Guo, D., Zhang, Z., Yin, C.-C., Chen, Y. & Xiang, Y. (2017). Protein Cell, 8, 219–224. He, R., Leeson, A., Ballantine, M., Andonov, A., Baker, L., Dobie, F., Li, Y., Bastien, N., Feldmann, H., Strocher, U., Theriault, S., Cutts, T., Cao, J., Booth, T. F., Plummer, F. A., Tyler, S. & Li, X. (2004). Virus Res. 105, 121–125. Hsin, W.-C., Chang, C.-H., Chang, C.-Y., Peng, W.-H., Chien, C.-L., Chang, M.-F. & Chang, S. C. (2018). J. Biomed. Sci. 25, 47. Jayaram, H., Fan, H., Bowman, B. R., Ooi, A., Jayaram, J., Collisson, E. W., Lescar, J. & Prasad, B. V. (2006). J. Virol. 80, 6612–6620. Kabsch, W. (2010). Acta Cryst. D66, 125–132. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J. & Svergun, D. I. (2003). J. Appl. Cryst. 36, 1277–1282. Kuo, L., Koetzner, C. A., Hurst, K. R. & Masters, P. S. (2014). J. Virol. 88, 4451–4465. Lantez, V., Dalle, K., Charrel, R., Baronti, C., Canard, B. & Coutard, B. (2011). PLoS Negl. Trop. Dis. 5, e936. Ma, Y., Tong, X., Xu, X., Li, X., Lou, Z. & Rao, Z. (2010). Protein Cell, 1, 688–697.

Acta Cryst. (2019). D75, 8–15

McBride, R., van Zyl, M. & Fielding, B. C. (2014). Viruses, 6, 2991– 3018. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. Papageorgiou, N., Lichie`re, J., Baklouti, A., Ferron, F., Se´vajol, M., Canard, B. & Coutard, B. (2016). Acta Cryst. D72, 192–202. Peng, T.-Y., Lee, K.-R. & Tarn, W.-Y. (2008). FEBS J. 275, 4152–4163. Petoukhov, M. V. & Svergun, D. I. (2007). Curr. Opin. Struct. Biol. 17, 562–571. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. & Ferrin, T. E. (2004). J. Comput. Chem. 25, 1605–1612. Robert, X. & Gouet, P. (2014). Nucleic Acids Res. 42, W320–W324. Shekhar, S., Pernier, J. & Carlier, M.-F. (2016). J. Cell Sci. 129, 1085– 1091. Stein, N. (2008). J. Appl. Cryst. 41, 641–643. Surjit, M., Kumar, R., Mishra, R. N., Reddy, M. K., Chow, V. T. K. & Lal, S. K. (2005). J. Virol. 79, 11476–11486. Svergun, D. I. (1992). J. Appl. Cryst. 25, 495–503. Szelazek, B., Kabala, W., Kus, K., Zdzalik, M., Twarda-Clapa, A., Golik, P., Burmistrz, M., Florek, D., Wladyka, B., Pyrc, K. & Dubin, G. (2017). J. Virol. 91, e02503-16. Takeda, M., Chang, C.-K., Ikeya, T., Gu¨ntert, P., Chang, Y.-H., Hsu, Y.-L., Huang, T.-H. & Kainosho, M. (2008). J. Mol. Biol. 380, 608– 622. Vonrhein, C., Flensburg, C., Keller, P., Sharff, A., Smart, O., Paciorek, W., Womack, T. & Bricogne, G. (2011). Acta Cryst. D67, 293–302. Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., Jain, S., Lewis, S. M., Arendall, W. B., Snoeyink, J., Adams, P. D., Lovell, S. C., Richardson, J. S. & Richardson, D. C. (2018). Protein Sci. 27, 293–315. Wu, C.-H., Yeh, S.-H., Tsay, Y.-G., Shieh, Y.-H., Kao, C.-L., Chen, Y.-S., Wang, S.-H., Kuo, T.-J., Chen, D.-S. & Chen, P.-J. (2009). J. Biol. Chem. 284, 5229–5239. Yu, I.-M., Oldham, M. L., Zhang, J. & Chen, J. (2006). J. Biol. Chem. 281, 17134–17139. Zuwała, K., Golda, A., Kabala, W., Burmistrz, M., Zdzalik, M., Nowak, P., Kedracka-Krok, S., Zarebski, M., Dobrucki, J., Florek, D., Zeglen, S., Wojarski, J., Potempa, J., Dubin, G. & Pyrc, K. (2015). PLoS One, 10, e0117833.

Nguyen et al.



C-terminal region of the MERS-CoV nucleoprotein

15